| Literature DB >> 31828190 |
Karin Chen1, Leo Satlof1,2, Guillaume Stoffels2, Udithi Kothapalli1,2, Noah Ziluck1,2, Maribel Lema1,3, Leonid Poretsky1,2,3, Dimiter Avtanski1,2,3.
Abstract
Metastatic breast cancer is the most advanced stage of breast cancer and the leading cause of breast cancer mortality. Although understanding of the cancer progression and metastasis process has improved, the bi-directional communication between the tumor cell and the tumor microenvironment is still not well understood. Breast cancer cells are highly secretory, and their secretory activity is modulated by a variety of inflammatory stimuli present in the tumor microenvironment. Here, we characterized the cytokine expression in human breast cancer cells (MDA-MB-231, MCF-7, T-47D, and BT-474) in vitro using 41 cytokine MILLIPLEX assay. Further, we compared cytokine expression in breast cancer cells to those in non-tumorigenic human breast epithelial MCF-10A cells.Entities:
Keywords: Breast cancer; Cytokine; Inflammation; Tumor microenvironment
Year: 2019 PMID: 31828190 PMCID: PMC6889457 DOI: 10.1016/j.dib.2019.104798
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Categorization and molecular characteristics of the cell lines used.
| Cell Line | ER | PR | HER2 | BRCA1 | Subtype | Tumor |
|---|---|---|---|---|---|---|
| MCF-10A | – | – | – | WT | B | N/A |
| MDA-MB-231 | – | – | – | WT | TNB | AC |
| MCF-7 | + | + | – | WT | LA | IDC |
| T-47D | + | + | – | WT | LA | IDC |
| BT-474 | + | + | + | WT | LB | IDC |
[1,2] ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2; BRCA1, breast cancer gene 1; WT, wild type; TNB, triple-negative B; B, basal; LA, luminal A; LB, luminal B; AC, adenocarcinoma; IDC, invasive lobular carcinoma.
List of cytokines measured by MILLIPLEX assay.
| Abbreviation | Full name | Synonyms |
|---|---|---|
| TNFα | Tumor Necrosis Factor Alpha | TNF-α, TNF-alpha, TNFA, TNF, TNFSF2, TNLG1F, DIF |
| TNFβ | Tumor Necrosis Factor Beta | TNF-β, TNF-beta, TNFB, TNFSF1, LT, TNLG1E, Lymphotoxin-α, Lymphotoxin Alpha, LTA |
| IFN-α2 | Interferon Alpha 2 | IFNA, IFNA2, IFNA2B, IFN-alphaA, INDA2 |
| IFN-γ | Interferon gamma | IFNγ, IFNgamma, IFN-gamma, IFN-g, IFI, TCRalpha |
| CCL2 | Chemokine (C–C Motif) Ligand 2 | MCP-1, MCP1, GDCF-2, HC11, HSMCR30, MCAF, SCYA2, SMC-CF |
| CCL3 | Chemokine (C–C Motif) Ligand 3 | MIP-1α, MIP-1-alpha, MIP1A, SCYA3, G0S19-1, LD78ALPHA |
| CCL4 | Chemokine (C–C Motif) Ligand 4 | MIP-1β. MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4, ACT2, AT744.1, G-26, HC21, LAG-1, LAG1 |
| CCL5 | Chemokine (C–C Motif) Ligand 5 | RANTES, eoCP, SCYA5, TCP228, D17S136E, SIS-delta, SISd |
| CCL7 | Chemokine (C–C Motif) Ligand 7 | CCL7, MCP-3, MCP3, FIC, MARC, NC28, SCYA6, SCYA7 |
| CCL11 | C–C Motif Chemokine Ligand 2 | Eotaxin-1, HC11, MCAF, MCP1, MCP-1, SCYA2, GDCF-2, SMC-CF, HSMCR30 |
| CCL22 | C–C Motif Chemokine 22 | MDC, ABCD-1, SCYA22, STCP-1, DC/B-CK, A-152E5.1 |
| CXCL1 | C-X-C Motif Chemokine Ligand 1 | Groucho, GRO, GRO1, GROA, GROa, MGSA, MGSA-alpha, MGSA-A, MGSA-a, NAP-3, SCYB1, FSP |
| CXCL10 | C-X-C Motif Chemokine Ligand 10 | IP-10, INP10, IFI10, SCYB10, gIP-10, C7, crg-2, mob-1 |
| CX3CL1 | Chemokine (C-X3-C Motif) Ligand 1 | Fractalkine, Neurotactin, ABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT, SCYD1 |
| IL-1α | Interleukin 1 Alpha | IL1α, IL-1alpha, IL1alpha, IL1-ALPHA, IL-1A, IL1A, IL1, Hematopoietin 1 |
| IL-1β | Interleukin 1 Beta | IL1-beta, IL1beta, IL1-BETA, IL-1, IL1, IL1F2 |
| IL-2 | Interleukin 2 | IL2, TCGF, Lymphokine |
| IL-3 | Interleukin 3 | IL3, MCGF, MULTI-CSF |
| IL-4 | Interleukin 4 | IL4, BCGF-1, BCGF1, BSF-1, BSF1 |
| IL-5 | Interleukin 5 | IL5, EDF, TRF |
| IL-6 | Interleukin 6 | IL6, CDF, HGF, HSF, BSF-2, BSF2, IFNB2, IFN-beta-2 |
| IL-7 | Interleukin 7 | IL7 |
| IL-8 | Interleukin 8 | IL8, CXCL8, NAF, GCP-1, GCP1, LECT, LUCT, NAP-1, NAP1, GCP-1, LYNAP, MDNCF, MONAP |
| IL-9 | Interleukin 9 | IL9, HP40, P40 |
| IL-10 | Interleukin 10 | IL10, IL10A, CSIF, GVHDS, TGIF |
| IL-12p40 | Interleukin 12 Subunit p40 | IL12B, IL-12B, CLMF, CLMF2, IMD28, IMD29, NKSF, NKSF2 |
| IL-12p70 | Interleukin 12 p70 (active heterodimer) | |
| IL-13 | Interleukin 13 | IL13, P600 |
| IL-15 | Interleukin 15 | IL15 |
| IL-17A | Interleukin 17A | IL17A, IL-17, IL17, CTLA-8, CTLA8 |
| IL-1RA | Interleukin 1 Receptor Antagonist | IL1RA, IL-1ra, IL-1ra3, IL1RN, IL-1RN, IL1F3, ICIL-1RA, MVCD4, DIRA, IRAP |
| G-CSF | Granulocyte Colony-Stimulating Factor | GCSF, CSF3, CSF3OS, C17orf33 |
| GM-CSF | Granulocyte-Macrophage Colony-Stimulating Factor | CSF2, CSF |
| FLT3L | FMS-Like Tyrosine Kinase 3 Ligand | FL, FLG3L, FLT3LG |
| sCD40L | Soluble Cluster of Differentiation 40 Ligand | |
| EGF | Epidermal Growth Factor | HOMG4, URG |
| FGF-2 | Fibroblast Growth Factor 2 | FGF2, FGFB, BFGF, HBGF-2 |
| TGFα | Transforming Growth Factor Alpha | TGFA |
| PDGF-AA | Platelet-Derived Growth Factor AA Homodimer | |
| PDGF-AB/BB | Platelet-Derived Growth Factor AB/BB Homodimers | |
| VEGF-A | Vascular Endothelial Growth Factor A | VEGFA, VEGF, VPF, MVCD1 |
Basal cytokine secretion in breast cancer cell lines.
| Cytokine | 24h | 48h | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| MCF-10A | MDA-MB-231 | MCF-7 | T-47D | BT-474 | MCF-10A | MDA-MB-231 | MCF-7 | T-47D | BT-474 | |
| TNFα | <2.950 | 7.275 (±0.179) | <2.560 | 45.895 (±11.591) | 15.328 (±0.434) | 4.103 (±0.109) | 14.935 (±0.546) | <2.560 | 33.630 (±9.101) | 13.898 (±2.355) |
| TNFβ | <2.485 | <2.493 | <2.260 | <2.348 | <2.260 | <2.735 | <3.620 | <2.260 | <2.398 | <2.398 |
| IFN-α2 | <5.088 | <13.510 | <4.845 | <7.805 | <8.313 | <7.425 | <13.278 | <4.970 | 12.123 (±3.010) | 14.998 (±2.485) |
| IFN-γ | 3.843 (±0.414) | 8.290 (±0.655) | <1.860 | 4.948 (±0.463) | <1.875 | 3.328 (±0.292) | 7.790 (±0.533) | <1.860 | 5.848 (±1.211) | <3.865 |
| CCL2 | 829.865 (±58.989) | 1069.333 (±47.394) | <3.020 | 3337.000 (±373.176) | 270.170 (±4.571) | 1665.750 (±100.659) | 2197.500 (±90.143) | <3.228 | 2739.750 (±683.225) | 616.520 (±146.576) |
| CCL3 | <7.930 | 10.745 (±0.345) | <7.930 | <7.930 | <7.930 | <7.930 | 21.803 (±0.770) | <7.930 | <7.930 | <7.930 |
| CCL4 | 4.370 (±0.167) | 7.793 (±0.231) | <2.890 | 43.030 (±8.784) | 3.985 (±0.170) | 5.028 (±0.153) | 12.783 (±0.106) | <2.890 | 26.075 (±5.572) | 4.735 (±0.747) |
| CCL5 | 8.970 (±0.143) | 102.598 (±1.836) | 5.545 (±0.236) | 232.223 (±19.932) | 154.808 (±1.343) | 15.265 (±0.452) | 180.860 (±5.135) | 6.910 (±0.678) | 226.218 (±38.228) | 370.975 (±81.655) |
| CCL7 | 12.333 (±0.661) | 12.373 (±0.856) | <3.188 | 10.858 (±1.531) | 4.708 (±0.336) | 13.038 (±0.279) | 14.145 (±1.080) | <3.188 | 8.675 (±1.097) | 6.263 (±1.233) |
| CCL11 | 9.215 (±0.193) | 9.470 (±0.254) | <2.990 | 3.845 (±0.245) | 4.183 (±0.353) | 9.515 (±0.325) | 10.098 (±0.232) | <2.990 | <3.915 | 4.118 (±0.210) |
| CCL22 | 9.205 (±1.055) | 12.430 (±0.430) | 8.713 (±0.541) | 12.753 (±1.462) | 17.815 (±1.015) | 10.213 (±0.642) | 14.900 (±1.402) | 10.345 (±0.179) | 10.750 (±1.686) | 68.720 (±21.248) |
| CXCL1 | 8732.750 (±605.110) | 4522.000 (±156.844) | 4.068 (±0.408) | 456.633 (±121.228) | 387.795 (±9.656) | 7983.750 (±551.861) | 10,511.000 (±762.600) | <3.688 | 249.928 (±70.653) | 1451.665 (±413.137) |
| CXCL10 | 143.163 (±5.162) | 372.870 (±16.491) | <1.655 | 2964.750 (±991.557) | 75.195 (±2.178) | 151.400 (±5.605) | 778.045 (±52.223) | 5.035 (±0.430) | 2951.205 (±840.243) | 207.890 (±63.633) |
| CX3CL1 | 49.290 (±3.842) | 164.840 (±4.438) | 21.543 (±1.511) | 44.715 (±2.424) | 92.060 (±6.627) | 60.225 (±2.750) | 323.065 (±11.234) | 20.505 (±0.913) | 52.313 (±8.922) | 336.315 (±116.011) |
| IL-1α | 8.985 (±0.297) | 17.460 (±0.187) | <2.560 | 5.265 (±0.220) | <2.560 | 12.563 (±1.887) | 35.945 (±2.826) | <2.560 | 6.508 (±0.554) | <2.560 |
| IL-1β | <2.770 | <2.770 | <2.770 | <2.770 | <2.770 | <2.770 | <2.770 | <2.770 | <2.770 | <2.770 |
| IL-2 | <2.670 | <2.670 | <2.670 | <2.670 | <2.670 | <2.670 | <2.670 | <2.670 | <2.670 | <2.670 |
| IL-3 | <2.570 | <2.570 | <2.570 | <2.570 | <2.570 | <2.570 | <2.570 | <2.570 | <2.570 | <2.570 |
| IL-4 | 74.775 (±6.307) | 61.715 (±6.151) | <2.703 | 14.198 (±2.139) | 8.208 (±0.502) | 77.108 (±6.463) | 87.700 (±4.876) | <2.703 (±0.415) | 9.453 (±2.059) | 22.758 (±6.739) |
| IL-5 | <2.790 | <2.790 | <2.790 | <2.790 | <2.790 | <2.790 | <2.790 | <2.790 | <2.790 | <2.790 |
| IL-6 | 21.295 (±0.856) | 4583.250 (±119.634) | <2.280 | <2.280 | 3.843 (±0.266) | 46.883 (±4.309) | 5391.00 (±502.887) | <2.280 | <2.485 | 4.423 (±0.194) |
| IL-7 | 4.725 (±0.540) | 16.398 (±1.352) | 2.728 (±0.759) | 5.920 (±1.182) | 7.343 (±1.935) | 6.728 (±0.849) | 17.173 (±1.438) | <1.820 | 6.668 (±1.515) | 6.578 (±1.174) |
| IL-8 | 6048.000 (±438.163) | 5568.250 (±291.235) | <1.750 | 24.558 (±8.036) | 278.205 (±11.059) | >6805.00 | 00 | <1.750 | 33.570 (±8.789) | 454.288 (±99.778) |
| IL-9 | <2.980 | <2.980 | <2.980 | <3.595 | <2.980 | <2.980 | <2.980 | <2.980 | 5.158 (±0.626) | <2.980 |
| IL-10 | 2.708 (±0.226) | 9.503 (±0.792) | <1.080 | 2.648 (±0.407) | <1.473 | 3.005 (±0.279) | 12.180 (±1.267) | <1.080 | 2.825 (±0.354) | <2.133 |
| IL-12p40 | 4.780 (±0.302) | 6.583 (±0.465) | <2.415 | 6.785 (±0.546) | 3.388 (±0.269) | 5.543 (±0.298) | 7.803 (±0.252) | <1.868 | 5.883 (±0.604) | 4.188 (±0.393) |
| IL-12p70 | <2.083 | 3.228 (±0.263) | <1.300 | <1.640 | <1.355 | <2.293 | 4.128 (±0.333) | <1.193 | <2.020 | <1.793 |
| IL-13 | 3.253 (±0.198) | 5.945 (±0.302) | <1.945 | 6.325 (±0.243) | <2.235 | 5.628 (±0.276) | 7.975 (±0.220) | <1.940 | 5.893 (±0.912) | <3.675 |
| IL-15 | 4.103 (±0.278) | 15.948 (±0.280) | <0.820 | 4.493 (±0.870) | 1.845 (±0.054) | 6.758 (±0.192) | 25.093 (±0.447) | <0.908 | 3.803 (±0.633) | 3.483 (±0.503) |
| IL-17A | 1.963 (±0.184) | 2.670 (±0.192) | <1.340 | <1.743 | <1.418 | 2.130 (±0.178) | 3.145 (±0.485) | <1.340 | <1.798 | <1.645 |
| IL-1RA | 8.918 (±0.528) | 18.138 (±0.941) | 4.168 (±0.477) | 9.645 (±1.276) | 5.593 (±0.361) | 13.190 (±1.039) | 24.433 (±1.700) | 4.093 (±0.299) | 9.313 (±1.333) | 14.175 (±4.190) |
| G-CSF | 357.355 (±31.119) | 337.920 (±6.059) | 4.438 (±0.224) | 52.563 (±4.055) | 30.685 (±5.760) | 428.770 (±42.610) | 1464.250 (±181.843) | 5.638 (±0.299) | 74.585 (±11.091) | 34.760 (±7.455) |
| GM-CSF | 29.400 (±1.513) | 1070.000 (±16.678) | <2.920 | 7.968 (±0.800 | <2.978 | 37.430 (±3.884) | 3871.750 (±101.647) | <2.920 | 8.048 (±1.245) | <4.253 |
| FLT3L | 8.170 (±0.318) | 16.123 (±0.289) | <2.915 | 11.138 (±1.771) | 8.370 (±0.320) | 9.973 (±0.365) | 24.038 (±0.268) | <2.798 | 7.940 (±1.345) | 19.983 (±3.394) |
| sCD40L | 3.503 (±0.580) | 5.683 (±0.739) | <2.010 | 4.418 (±0.644) | <2.078 | 4.225 (±0.379) | 7.445 (±0.859) | <2.010 | 4.448 (±1.000) | <3.158 |
| EGF | 5.685 (±0.172) | 6.845 (±0.296) | 3.853 (±0.219) | 4.637 (±0.257) | 4.883 (±0.206) | 6.053 (±0.160) | 7.095 (±0.409) | 3.725 (±0.134) | 5.038 (±0.578) | <4.068 |
| FGF-2 | 31.070 (±3.084) | 46.325 (±3.386) | 9.380 (±1.099) | 28.823 (±3.851) | 15.995 (±1.279) | 161.310 (±3.588) | 42.680 (±3.098) | 10.745 (±1.721) | 25.620 (±4.764) | 25.545 (±4.515) |
| TGFα | <2.800 | 10.168 (±0.210) | 9.348 (±0.247) | 8.935 (±1.131) | <2.800 | <2.800 | 13.255 (±0.373) | 14.285 (±0.249) | 6.033 (±0.627) | 3.798 (±0.445) |
| PDGF-AA | 55.013 (±2.143) | 85.943 (±1.684) | 42.038 (±0.879) | 61.323 (±17.375) | 45.478 (±0.624) | 99.003 (±3.448) | 179.295 (±1.338) | 104.150 (±3.264) | 42.478 (±11.780) | 665.713 (±217.050) |
| PDGF-AB/BB | 12.120 (±0.833) | 37.260 (±0.721) | 201.665 (±13.144) | 417.443 (±163.571) | 28.715 (±0.964) | 12.195 (±0.797) | 74.628 (±1.039) | 617.865 (±6.517) | 270.130 (±67.436) | 1296.283 (±434.299) |
| VEGF-A | 151.368 (±5.500) | 1775.415 (±112.696) | 98.468 (±3.220) | 265.685 (±76.573) | 216.440 (±3.643) | 276.750 (±9.789) | 2070.230 (±51.826) | 219.028 (±5.175) | 248.513 (±50.523) | 316.485 (±8.822) |
Cytokine levels [pg/ml] in cell culture medium collected after 24 and 48 hours, measured by MILLIPLEX assay. Each value represents the mean of measurements made in 4 setups. Some setup measurements were below or above assay detection level. If one or more of the 4 measurements in a group were below (above) detection level, then those values were assigned the threshold level and the corresponding mean was reported using the “less than” (“greater than”) symbol. Note that there was no situation in which the 4 setup measurements contained values both above and below detection level.
Comparison of cytokine expression between the four breast cancer cell lines and breast non-tumorigenic epithelial cells.
| Cytokine | 24h | 48h | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF-10A | MDA-MB-231 | MCF-7 | T-47D | BT-474 | Statistics | MCF-10A | MDA-MB-231 | MCF-7 | T-47D | BT-474 | Statistics | |
| TNFα | <1.548 | 2.862 (±0.036) | <1.356 | 5.418 (±0.315) | 3.936 (±0.040) | a, p = 0.0012, ** | 2.035 (±0.039) | 3.898 (±0.053) | <1.356 | 4.893 (±0.422) | 3.732 (±0.252) | a, p = 0.0022, ** |
| TNFβ | <1.307 | <1.516 | <1.176 | 1.228 | <1.176 | a, p = 0.2416, NS | <1.429 | <1.802 | <1.176 | <1.255 | <1.255 | a, p = 0.1000, NS |
| IFN-α2 | <2.141 | <2.977 | <2.201 | <2.511 | <2.536 | a, p = 0.9485, NS | <2.486 | <2.968 | <2.117 | 3.564 (±0.180) | 3.776 (±0.342) | a, p = 0.2487, NS |
| IFN-γ | 1.916 (±0.161) | 3.040 (±0.107) | <0.895 | 2.288 (±0.134) | <0.907 | a, p = 0.0014, ** | 1.719 (±0.121) | 2.951 (±0.101) | <0.895 | 2.478 (±0.275) | <1.756 | a, p = 0.0043, ** |
| CCL2 | 9.685 (±0.105) | 10.058 (±0.065) | <1.595 | 11.677 (±0.163) | 8.077 (±0.024) | a, p = 0.0010, ** | 10.693 (±0.092) | 11.098 (±0.059) | <1.688 | 11.276 (±0.376) | 9.143 (±0.380) | a, p = 0.0033, ** |
| CCL3 | <2.987 | 3.423 (±0.046) | <2.987 | <2.987 | <2.987 | a, p = 0.0009, *** | <2.987 | 4.444 (±0.051) | <2.987 | <2.987 | <2.987 | a, p = 0.0009, *** |
| CCL4 | 2.126 (±0.041) | 2.960 (±0.042) | <1.531 | 5.356 (±0.277) | 1.969 (±0.154) | a, p = 0.0014, ** | 2.328 (±0.044) | 3.676 (±0.012) | <1.531 | 4.627 (±0.285) | 2.190 (±0.224) | a, p = 0.0015, ** |
| CCL5 | 3.165 (±0.023) | 6.680 (±0.026) | 2.468 (±0.059) | 7.844 (±0.123) | 7.274 (±0.013) | a, p < 0.0001, **** | 3.930 (±0.043) | 7.497 (±0.041) | 2.768 (±0.141) | 7.757 (±0.251) | 8.422 (±0.335) | a, p < 0.0001, **** |
| CCL7 | 3.618 (±0.077) | 3.619 (±0.097) | <1.672 | 3.406 (±0.186) | 2.224 (±0.101) | a, p = 0.0044, ** | 3.704 (±0.031) | 3.805 (±0.131) | <1.672 | 3.082 (±0.184) | 2.550 (±0.315) | a, p = 0.0022, ** |
| CCL11 | 3.203 (±0.031) | 3.242 (±0.038) | <1.580 | 1.934 (±0.094) | 2.048 (±0.128) | a, p = 0.0021, ** | 3.248 (±0.045) | 3.335 (±0.033) | <1.580 | <1.951 | 2.036 (±0.076) | a, p = 0.0024, ** |
| CCL22 | 3.171 (±0.173) | 3.633 (±0.050) | 3.115 (±0.088) | 3.645 (±0.162) | 4.148 (±0.083) | a, p = 0.0001, *** | 3.343 (±0.093) | 3.878 (±0.137) | 3.368 (±0.050) | 3.397 (±0.164) | 5.867 (±0.541) | a, p < 0.0001, **** |
| CXCL1 | 13.082 (±0.099) | 12.140 (±0.050) | 2.005 (±0.134) | 8.664 (±0.414) | 8.598 (±0.036) | a, p < 0.0001, **** | 12.953 (±0.097) | 13.348 (±0.105) | <1.828 | 7.858 (±0.333) | 10.319 (±0.471) | a, p = 0.0012, ** |
| CXCL10 | 7.159 (±0.053) | 8.538 (±0.064) | <0.523 | 11.396 (±0.370) | 6.231 (±0.042) | a, p = 0.0011, ** | 7.239 (±0.054) | 9.593 (±0.101) | 2.316 (±0.124) | 11.263 (±0.576) | 7.466 (±0.486) | a, p < 0.0001, **** |
| CX3CL1 | 5.609 (±0.118) | 7.360 (±0.070) | 4.419 (±0.101) | 5.476 (±0.078) | 6.513 (±0.102) | a, p < 0.0001, **** | 5.908 (±0.069) | 8.333 (±0.050) | 4.354 (±0.061) | 5.657 (±0.220) | 8.119 (±0.550) | a, p < 0.0001, **** |
| IL-1α | 3.165 (±0.048) | 4.126 (±0.015) | <1.356 | 2.393 (±0.061) | <1.356 | a, p = 0.0010, ** | 3.608 (±0.213) | 5.154 (±0.114) | <1.356 | 2.686 (±0.128) | <1.356 | a, p = 0.0010, ** |
| IL-1β | <1.470 | <1.470 | <1.470 | <1.470 | <1.470 | <1.470 | <1.470 | <1.470 | <1.470 | <1.470 | ||
| IL-2 | <1.417 | <1.417 | <1.417 | <1.417 | <1.417 | <1.417 | <1.417 | <1.417 | <1.417 | <1.417 | ||
| IL-3 | <1.362 | <1.362 | <1.362 | <1.362 | <1.362 | <1.362 | <1.362 | <1.362 | <1.362 | <1.362 | ||
| IL-4 | 6.209 (±0.121) | 5.929 (±0.131) | <1.417 | 3.788 (±0.199) | 3.029 (±0.085) | a, p = 0.0013, ** | 6.253 (±0.123) | 6.448 (±0.080) | <1.417 | 3.142 (±0.306) | 4.301 (±0.490) | a, p = 0.0018, ** |
| IL-5 | <1.480 | <1.480 | <1.480 | <1.480 | <1.480 | <1.480 | <1.480 | <1.480 | <1.480 | <1.480 | ||
| IL-6 | 4.409 (±0.058) | 12.161 (±0.038) | <1.189 | <1.189 | 1.932 (±0.096) | a, p = 0.0010, ** | 5.532 (±0.135) | 12.378 (±0.132) | <1.189 | <1.300 | 2.141 (±0.064) | a, p = 0.0011, ** |
| IL-7 | 2.214 (±0.155) | 4.023 (±0.109) | 1.260 (±0.432) | 2.474 (±0.302) | 2.717 (±0.401) | a, p = 0.0003, *** | 2.717 (±0.178) | 4.087 (±0.121) | <0.803 | 2.619 (±0.344) | 2.644 (±0.271) | a, p = 0.0054, ** |
| IL-8 | 12.551 (±0.103) | 12.427 (±0.124) | <0.807 | 4.481 (±0.350) | 8.117 (±0.057) | a, p = 0.0015, ** | >12.785 | >12.970 | <0.807 | 4.925 (±0.406) | 8.715 (±0.334) | a, p = 0.0011, ** |
| IL-9 | <1.575 | <1.575 | <1.575 | <1.838 | <1.575 | a, p = 0.0099 ** | <1.575 | <1.575 | <1.575 | 2.334 (±0.178) | <1.575 | a, p = 0.0009, *** |
| IL-10 | 1.421 (±0.125) | 3.234 (±0.118) | <0.111 | 1.357 (±0.209) | 0.504 | a, p = 0.0021, ** | 1.569 (±0.135) | 3.583 (±0.149) | <0.111 | 1.461 (±0.195) | <1.002 | a, p = 0.0039, ** |
| IL-12p40 | 2.248 (±0.094) | 2.707 (±0.110) | <1.251 | 2.748 (±0.121) | 1.747 (±0.115) | a, p < 0.0001, **** | 2.464 (±0.076) | 2.962 (±0.048) | <0.900 | 2.535 (±0.141) | 2.047 (±0.133) | a, p = 0.0025, ** |
| IL-12p70 | <0.973 | 1.675 (±0.121) | <0.350 | <0.613 | <0.401 | a, p = 0.0198, * | <1.086 | 1.987 (±0.243) | <0.241 | <0.928 | <0.758 | a, p = 0.0425, * |
| IL-13 | 1.694 (±0.086) | 2.566 (±0.074) | <0.956 | 2.658 (±0.054) | <1.140 | a, p = 0.0017, ** | 2.487 (±0.071) | 2.994 (±0.039) | <0.956 | 2.516 (±0.205) | <1.773 | a, p = 0.0034, ** |
| IL-15 | 2.026 (±0.102) | 3.995 (±0.025) | < −0.286 | 2.083 (±0.288) | 0.882 (±0.042) | a, p = 0.0015, ** | 2.755 (±0.041) | 6.648 (±0.026) | < −0.148 | 1.887 (±0.199) | 1.776 (±0.154) | a, p = 0.0016, ** |
| IL-17A | 0.954 (±0.136) | 1.405 (±0.105) | <0.422 | <0.783 | <0.500 | a, p = 0.0053, ** | 1.075 (±0.126) | 1.604 (±0.216) | <0.422 | <0.819 | <0.693 | a, p = 0.0074, ** |
| IL-1RA | 3.149 (±0.082) | 4.175 (±0.077) | 2.033 (±0.154) | 3.231 (±0.195) | 2.474 (±0.095) | a, p < 0.0001, **** | 3.710 (±0.105) | 4.600 (±0.099) | 2.021 (±0.108) | 3.180 (±0.200) | 3.661 (±0.426) | a, p < 0.0001, **** |
| G-CSF | 8.465 (±0.125) | 8.400 (±0.026) | 2.145 (±0.067) | 5.703 (±0.113) | 4.874 (±0.267) | a, p < 0.0001, **** | 8.720 (±0.158) | 10.482 (±0.181) | 2.489 (±0.076) | 6.173 (±0.193) | 5.032 (±0.301) | a, p < 0.0001, **** |
| GM-CSF | 4.872 (±0.075) | 10.063 (±0.023) | <1.546 | 2.972 (±0.146) | <1.573 | a, p = 0.0011, ** | 5.203 (±0.150) | 11.917 (±0.038) | <1.546 | 2.957 (±0.223) | <2.059 | a, p = 0.0011, ** |
| FLT3L | 3.027 (±0.056) | 4.010 (±0.026) | <1.525 | 3.439 (±0.197) | 3.063 (±0.050) | a, p = 0.0037, ** | 3.316 (±0.046) | 4.587 (±0.016) | <1.459 | 2.941 (±0.211) | 4.199 (±0.365) | a, p = 0.0039, ** |
| sCD40L | 1.745 (±0.252) | 2.467 (±0.199) | <1.007 | 2.093 (±0.227) | <1.053 | a, p = 0.0041, ** | 2.061 (±0.134) | 2.876 (±0.147) | <1.007 | 2.034 (±0.347) | <1.603 | a, p = 0.0071, ** |
| EGF | 2.505 (±0.045) | 2.771 (±0.065) | 1.938 (±0.087) | 2.207 (±0.080) | 2.256 (±0.176) | a, p = 0.0004, *** | 2.596 (±0.039) | 2.820 (±0.084) | 1.895 (±0.051) | 2.311 (±0.142) | <1.971 | a, p = 0.0065, ** |
| FGF-2 | 4.936 (±0.144) | 5.522 (±0.106) | 3.197 (±0.183) | 4.806 (±0.208) | 3.990 (±0.093) | a, p < 0.0001, **** | 7.333 (±0.032) | 5.404 (±0.108) | 3.365 (±0.246) | 4.627 (±0.218) | 4.599 (±0.277) | a, p < 0.0001, **** |
| TGFα | <1.485 | 3.345 (±0.030) | 3.223 (±0.038) | 3.124 (±0.186) | <1.485 | a, p = 0.0038, ** | <1.485 | 3.727 (±0.042) | 3.836 (±0.025) | 2.571 (±0.148) | 1.895 (±0.172) | a, p = 0.0013, ** |
| PDGF-AA | 5.778 (±0.056) | 6.424 (±0.029) | 5.393 (±0.030) | 5.740 (±0.447) | 5.507 (±0.020) | a, p = 0.0228, * | 6.627 (±0.051) | 7.486 (±0.011) | 6.700 (±0.046) | 5.256 (±0.408) | 9.247 (±0.394) | a, p < 0.0001, **** |
| PDGF-AB/BB | 3.588 (±0.104) | 5.179 (±0.033) | 7.647 (±0.095) | 8.473 (±0.486) | 4.841 (±0.048) | a, p < 0.0001, **** | 3.598 (±0.101) | 6.221 (±0.020) | 9.271 (±0.015) | 8.043 (±0.190) | 10.309 (±0.176) | a, p < 0.0001, **** |
| VEGF-A | 7.239 (±0.053) | 10.785 (±0.093) | 6.619 (±0.047) | 7.846 (±0.457) | 7.757 (±0.024) | a, p < 0.0001, **** | 8.110 (±0.051) | 11.014 (±0.036) | 7.774 (±0.034) | 7.846 (±0.345) | 8.304 (±0.039) | a, p < 0.0001, **** |
Cytokine levels are presented in log scale, base 2 (±SEM). Each value is the mean of measurements from 4 independent setups. In the case of values below or above detection level, means and p-values are reported using “less than” or “greater than” symbols. a, ANOVA; b, MCF-10A vs. MDA-MB-231; c, MCF-10A vs. MCF-7; d, MCF-10A vs. T-47D; e, MCF-10A vs. BT-474; f, MDA-MB-231 vs. MCF-7; g, MDA-MB-231 vs. T-47D; h, MDA-MB-231 vs. BT-474; i, MCF-7 vs. T-47D; j, MCF-7 vs. BT-474; k, T-47D vs. BT-474; NS, non-significant (p > 0.05); *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001.
Specifications Table
| Subject area | |
| More specific subject area | Oncology |
| Type of data | Tables |
| How data was acquired | MILLIPLEX assay |
| Data format | Raw and analyzed |
| Experimental factors | Cytokine levels in conditioned medium of human breast cancer and non-tumorigenic breast epithelial cells harvested at 24 and 48 hours. |
| Experimental features | Cytokine levels in cell culture conditioned medium from various human breast cancer cell lines (MDA-MB-231, MCF-7, T-47D, and BT-474 cells) were measured and compared to those from non-tumorigenic breast epithelial MCF-10A cells. |
| Data source location | New York, New York, USA |
| On a public repository |
Breast cancer cells are highly secretory cells producing variety of cytokines and other molecules that can modulate or are modulated by the tumor microenvironment. Inflammation mediates the initiation and progression of breast cancer, including directly affecting secretory activity of the cancer cells. Understanding the bi-directional communication between tumor microenvironment and the cancer cells can lead to the development of novel therapies for breast cancer. |